U.S. President Donald Trump has unveiled a sweeping new round of import tariffs, citing national security concerns and the need to strengthen domestic manufacturing.
Starting October 1, 2025, the following measures will take effect:
- 100% tariffs on branded pharmaceutical drugs — unless the manufacturer is currently building or expanding U.S. production facilities.
- 25% tariffs on heavy-duty trucks and related imports.
- 50% tariffs on kitchen cabinets and bathroom vanities.
- 30% tariffs on upholstered furniture.
Trump stated that revenue from these tariffs would help provide direct support to American farmers, promising financial relief until the new measures begin to benefit domestic producers.
The pharmaceutical sector reacted immediately, with major companies such as Roche and Novartis pointing to existing U.S. expansion plans that may shield them from the harshest penalties. Meanwhile, Asian drugmakers and suppliers saw share prices fall sharply.
Economists warn the tariffs could increase healthcare costs and drive inflation higher, while trade partners are considering their responses. Analysts also note that the moves risk escalating trade tensions at a time of global economic uncertainty.
Trump defended the policy, saying:
“America must never again depend on foreign powers for critical medicines, vehicles, or essential goods. These tariffs protect our workers, rebuild our factories, and make us strong again.”
The announcement comes amid broader debates over trade, globalization, and the balance between economic security and consumer costs.
